Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze TRDA stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TRDA investment potential.

What is TRDA stock price today?

Get real-time TRDA stock price, historical data, and price charts on Financhill. Track TRDA performance with our advanced analysis tools.

Is TRDA a good investment?

Evaluate TRDA investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy TRDA stock?

To buy TRDA stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TRDA?

View detailed market capitalization data and company valuation metrics for TRDA on our comprehensive analysis page.

What is the P/E ratio of TRDA?

Use our fundamental analysis tools to view TRDA P/E ratio and compare valuation metrics with industry peers.

What are TRDA earnings?

View TRDA earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Entrada Therapeutics, Inc. Stock Predictions

Missed $0.81? RAD Intel Now Open at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

TRDA
Entrada Therapeutics, Inc.

Last Price:

$10.18

Seasonality Move:

-3.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Still Time to Get In: RAD Intel at $0.85/Share

Entrada Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Entrada Therapeutics, Inc. has on average historically fallen by 20.6% based on the past 3 years of stock performance.
Entrada Therapeutics, Inc. has fallen lower in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Is Entrada Therapeutics, Inc. Stock Undervalued?

The current Entrada Therapeutics, Inc. [TRDA] share price is $10.16. The Score for TRDA is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
TRDA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Entrada Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Entrada Therapeutics, Inc. has on average historically fallen by 20.6% based on the past 3 years of stock performance.

Entrada Therapeutics, Inc. Stock Rating

Buy

Entrada Therapeutics, Inc. (TRDA) is a Buy

Is Entrada Therapeutics, Inc. overpriced?

Entrada Therapeutics, Inc. has fallen lower in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Entrada Therapeutics, Inc. Stock Price History

Is TRDA stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

entradatx.com

52-Week Data

52-Week High:

21.79

52-Week Low:

4.93

Prediction Charts

Market Cap:

388.3M

Price in USD:

10.16

Volume:

123.9K

Beta:

-0.12

Technical Analysis

SMA50:

7.39

SMA100:

6.51

SMA200:

7.64

52-Wk Change:

-49.1%

Stock Predictions

Is Entrada Therapeutics, Inc. stock public?

Yes, Entrada Therapeutics, Inc. is a publicly traded company.
What is the Entrada Therapeutics, Inc. stock quote today?

The Entrada Therapeutics, Inc. stock price is 10.16 USD today.
How to buy Entrada Therapeutics, Inc. stock online?

You can buy Entrada Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	8.68	8.75	9.15	8.51
Nov-17	8.66	8.47	9.04	8.17
Nov-18	8.46	8.82	9.12	8.30
Nov-19	8.72	8.73	8.92	8.44
Nov-20	8.85	9.17	9.29	8.78
Nov-21	9.16	10.11	10.17	9.15
Nov-24	10.13	9.89	10.45	9.64
Nov-25	10.15	10.12	10.75	10.11
Nov-26	10.15	10.08	10.33	9.96
Nov-28	10.06	10.27	10.32	9.91
Dec-1	10.14	9.91	10.30	9.79
Dec-2	9.80	9.85	9.99	9.49
Dec-3	9.84	10.07	10.12	9.40
Dec-4	9.94	10.16	10.38	9.52

Entrada Therapeutics, Inc. Earnings

Entrada Therapeutics, Inc. Earnings Report: Per Share Entrada Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Entrada Therapeutics, Inc. Forecast Revenue Growth

Entrada Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Entrada Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.44 per share, and a decrease next year of $0.64 per share.

* Entrada Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.